Go to homepage

autogenous vaccines

Check our solutions and see what we can offer depending on the animal species

what is an autogenous vaccine?

Autogenous vaccine: inactivated immunological veterinary medicinal products which are manufactured from pathogens and antigens obtained from an animal or animals in an epidemiological unit and used for the treatment of that animal or those animals in the same epidemiological unit or for the treatment of an animal or animals in a unit having a confirmed epidemiological link.

Autogenous vaccine definition given by: REGULATION (EU) 2019/6 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC

Specific: manufactured from pathogenic strains obtained from the farm itself once they have been identified and antigenically characterized by serotype, virulence factors or genetic sequencing; intended for the farm or epidemiological unit itself.

Updated: constant updating of vaccines with the incorporation of recent strains as per new diagnoses.

Combinables: in the case of multi-factorial processes the incorporation of several pathogens in the same autogenous vaccine is necessary.

Secure: they are inactivated, in no case can they reproduce the disease.

when should autogenous vaccines be administered?

If there is no veterinary vaccine registered for a given pathogen for a specific animal species; if the registered vaccine does not include the antigenic variation identified in the target farm; or if the registered vaccine has proven to be inefficient.

For the control of infectious processes present in farms by immunoprophylaxis.

Autogenous vaccines must be developed by an authorized laboratory (REG Exopol No: 235/50/015-A).

Autogenous vaccines must be dispensed on veterinary prescription after confirmatory laboratory diagnosis.

what are the steps we follow for the production of autogenous vaccines?


confirmation of causative agent



quality control

packaging and shipping to farm